Your browser doesn't support javascript.
loading
A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases.
Wenzel, Hans H B; Hardie, Anna N; Moncada-Torres, Arturo; Høgdall, Claus K; Bekkers, Ruud L M; Falconer, Henrik; Jensen, Pernille T; Nijman, Hans W; van der Aa, Maaike A; Martin, Frank; van Gestel, Anna J; Lemmens, Valery E P P; Dahm-Kähler, Pernilla; Alfonzo, Emilia; Persson, Jan; Ekdahl, Linnea; Salehi, Sahar; Frøding, Ligita P; Markauskas, Algirdas; Fuglsang, Katrine; Schnack, Tine H.
Afiliación
  • Wenzel HHB; Department of Research & Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands; Department of Obstetrics and Gynaecology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: h.wenzel@iknl.nl.
  • Hardie AN; Department of Pelvic Cancer, Karolinska University Hospital and Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Moncada-Torres A; Department of Research & Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
  • Høgdall CK; Department of Gynaecology, Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Bekkers RLM; Department of Obstetrics and Gynaecology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, the Netherlands; Department of Obstetrics and Gynaecology, Catharina Hospital, Eindhoven, the Netherlands.
  • Falconer H; Department of Pelvic Cancer, Karolinska University Hospital and Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Jensen PT; Department of Gynaecology and Obstetrics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Nijman HW; Department of Obstetrics and Gynaecology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
  • van der Aa MA; Department of Research & Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
  • Martin F; Department of Research & Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
  • van Gestel AJ; Department of Research & Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
  • Lemmens VEPP; Department of Research & Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands; Department of Public Health, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.
  • Dahm-Kähler P; Department of Obstetrics and Gynaecology, Sahlgrenska University Hospital and Department of Obstetrics and Gynaecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Alfonzo E; Department of Obstetrics and Gynaecology, Sahlgrenska University Hospital and Department of Obstetrics and Gynaecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Persson J; Department of Obstetrics and Gynaecology, Division of Gynaecologic Oncology, Skåne University Hospital and Lund University Faculty of Medicine, Department of Clinical Sciences, Obstetrics and Gynaecology, Lund, Sweden.
  • Ekdahl L; Department of Obstetrics and Gynaecology, Division of Gynaecologic Oncology, Skåne University Hospital and Lund University Faculty of Medicine, Department of Clinical Sciences, Obstetrics and Gynaecology, Lund, Sweden.
  • Salehi S; Department of Pelvic Cancer, Karolinska University Hospital and Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Frøding LP; Department of Gynaecology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Markauskas A; Department of Gynaecology, Odense University Hospital, Odense, Denmark.
  • Fuglsang K; Department of Gynaecology and Obstetrics, Aarhus University Hospital, Aarhus, Denmark.
  • Schnack TH; Department of Gynaecology, Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Department of Gynaecology, Odense University Hospital, Odense, Denmark.
Eur J Cancer ; 185: 61-68, 2023 05.
Article en En | MEDLINE | ID: mdl-36965329
ABSTRACT

OBJECTIVE:

Lymph node metastases (pN+) in presumed early-stage cervical cancer negatively impact prognosis. Using federated learning, we aimed to develop a tool to identify a group of women at low risk of pN+, to guide the shared decision-making process concerning the extent of lymph node dissection.

METHODS:

Women with cervical cancer between 2005 and 2020 were identified retrospectively from population-based registries the Danish Gynaecological Cancer Database, Swedish Quality Registry for Gynaecologic Cancer and Netherlands Cancer Registry. Inclusion criteria were squamous cell carcinoma, adenocarcinoma or adenosquamous carcinoma; The International Federation of Gynecology and Obstetrics 2009 IA2, IB1 and IIA1; treatment with radical hysterectomy and pelvic lymph node assessment. We applied privacy-preserving federated logistic regression to identify risk factors of pN+. Significant factors were used to stratify the risk of pN+.

RESULTS:

We included 3606 women (pN+ 11%). The most important risk factors of pN+ were lymphovascular space invasion (LVSI) (odds ratio [OR] 5.16, 95% confidence interval [CI], 4.59-5.79), tumour size 21-40 mm (OR 2.14, 95% CI, 1.89-2.43) and depth of invasion>10 mm (OR 1.81, 95% CI, 1.59-2.08). A group of 1469 women (41%)-with tumours without LVSI, tumour size ≤20 mm, and depth of invasion ≤10 mm-had a very low risk of pN+ (2.4%, 95% CI, 1.7-3.3%).

CONCLUSION:

Early-stage cervical cancer without LVSI, a tumour size ≤20 mm and depth of invasion ≤10 mm, confers a low risk of pN+. Based on an international privacy-preserving analysis, we developed a useful tool to guide the shared decision-making process regarding lymph node dissection.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias del Cuello Uterino Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Eur J Cancer Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias del Cuello Uterino Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Eur J Cancer Año: 2023 Tipo del documento: Article